AC Immune Correlations
ACIU Stock | USD 2.38 0.04 1.65% |
The correlation of AC Immune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AC Immune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AC Immune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between AC Immune and NYA is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AC Immune and NYA in the same portfolio, assuming nothing else is changed.
ACIU |
The ability to find closely correlated positions to AC Immune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AC Immune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AC Immune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AC Immune to buy it.
Moving together with ACIU Stock
0.8 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
0.62 | GILD | Gilead Sciences Earnings Call Tomorrow | PairCorr |
Moving against ACIU Stock
0.71 | ACB | Aurora Cannabis Trending | PairCorr |
0.65 | CGC | Canopy Growth Corp Trending | PairCorr |
0.64 | XFOR | X4 Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
0.54 | MRK | Merck Company Earnings Call Tomorrow | PairCorr |
0.45 | ELYM | Eliem Therapeutics | PairCorr |
0.43 | NRSNW | NeuroSense Therapeutics | PairCorr |
0.56 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ACIU Stock performing well and AC Immune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AC Immune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PMVP | 3.01 | 0.16 | 0.04 | 0.23 | 3.64 | 7.45 | 21.67 | |||
ELYM | 3.70 | 0.80 | 0.16 | (0.75) | 3.04 | 4.17 | 79.43 | |||
MNOV | 2.06 | (0.17) | 0.00 | (0.94) | 0.00 | 4.55 | 14.01 | |||
PHVS | 3.25 | (0.42) | 0.00 | (0.18) | 0.00 | 6.33 | 24.54 | |||
PEPG | 6.00 | 0.93 | 0.18 | 0.35 | 5.83 | 17.58 | 67.46 | |||
RGNX | 3.59 | 0.15 | 0.07 | 0.15 | 3.75 | 11.65 | 27.26 | |||
ANEB | 2.62 | 0.28 | 0.04 | (0.51) | 3.50 | 6.20 | 20.75 | |||
IVVD | 4.71 | (1.00) | 0.00 | (0.28) | 0.00 | 11.00 | 67.02 | |||
ABEO | 4.76 | (0.04) | 0.00 | 0.18 | 0.00 | 8.32 | 36.43 | |||
BDTX | 5.03 | 0.95 | 0.21 | 0.65 | 4.35 | 15.50 | 26.97 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in AC Immune without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
All Next | Launch Module |
AC Immune Corporate Directors
AC Immune corporate directors refer to members of an AC Immune board of directors. The board of directors generally takes responsibility for the AC Immune's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AC Immune's board members must vote for the resolution. The AC Immune board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Werner Lanthaler | Director | Profile | |
Roy Twyman | Director | Profile | |
Detlev Riesner | Member of the Board of Directors | Profile | |
Friedrich Halbach | Member of Board of Director | Profile |
Already Invested in AC Immune?
The danger of trading AC Immune is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AC Immune is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AC Immune. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AC Immune is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AC Immune is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ACIU Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ac Immune Stock. Highlighted below are key reports to facilitate an investment decision about Ac Immune Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for ACIU Stock analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is AC Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 0.175 | Quarterly Revenue Growth 14.8 K | Return On Assets (0.18) | Return On Equity (0.33) |
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.